IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Grant, M. B.
Right arrow Articles by Robison, W. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Grant, M. B.
Right arrow Articles by Robison, W. G.
(Investigative Ophthalmology and Visual Science. 2000;41:2296-2302.)
© 2000 by The Association for Research in Vision and Ophthalmology, Inc.

Plasminogen Activator Inhibitor (PAI)-1 Overexpression in Retinal Microvessels of PAI-1 Transgenic Mice

Maria B. Grant1, Polyxenie E. Spoerri1, Denifield W. Player2, David M. Bush1,3, E. Ann Ellis1, Sergio Caballero1 and W. Gerald Robison4

From the Departments of 1 Medicine and 2 Anatomy and Cell Biology, University of Florida, Gainesville; and the 3 National Eye Institute, Bethesda, Maryland.

PURPOSE. Previous studies have suggested that disturbances in plasminogen activator inhibitor (PAI)-1 may be relevant to the development of diabetic microvascular complications. To determine whether overexpression of PAI-1 in cells of retinal microvasculature would result in a disease similar to that observed in diabetes, ocular tissue from transgenic mice that overexpress human PAI-1 were examined.

METHODS. Transgenic mice were administered ZnSO4 (25 mM) in their water for up to 49 weeks to activate the metallothionein promoter and stimulate human PAI-1. Colloidal gold immunocytochemistry was used to quantify the human PAI-1 antigen at 7, 20, 34, and 49 weeks of ZnSO4 administration. Cross sections of retinal microvessels were examined by electron microscopy for changes in basement membrane (BM) thickness. Retinal digest preparations were examined by light microscopy for possible microangiopathy, including changes in endothelial cell-to-pericyte ratios.

RESULTS. Human PAI-1 immunoreactivity was detected throughout the retinal capillaries of transgenic mice receiving zinc and increased significantly (P < 0.001) after 20 to 49 weeks of ZnSO4 administration compared with age-matched transgenic control mice. At 20 and 49 weeks, retinal capillaries of transgenic mice that received zinc showed significantly thickened BMs compared with control animals (P < 0.001). Moreover, wholemounts of the retinal vasculature from PAI-1 transgenic mice demonstrated an increased endothelial cell-to-pericyte ratio.

CONCLUSIONS. PAI-1 overexpression in retinal microvasculature leads to retinal disease similar to that observed in diabetic retinopathy.




This article has been cited by other articles:


Home page
Br. J. Ophthalmol.Home page
R Kane, L Stevenson, C Godson, A W Stitt, and C O'Brien
Gremlin gene expression in bovine retinal pericytes exposed to elevated glucose
Br. J. Ophthalmol., December 1, 2005; 89(12): 1638 - 1642.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
W. Song, J. L. Barth, Y. Yu, K. Lu, A. Dashti, Y. Huang, C. K. Gittinger, W. S. Argraves, and T. J. Lyons
Effects of Oxidized and Glycated LDL on Gene Expression in Human Retinal Capillary Pericytes
Invest. Ophthalmol. Vis. Sci., August 1, 2005; 46(8): 2974 - 2982.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
A. V. Ljubimov, S. Caballero, A. M. Aoki, L. A. Pinna, M. B. Grant, and R. Castellon
Involvement of Protein Kinase CK2 in Angiogenesis and Retinal Neovascularization
Invest. Ophthalmol. Vis. Sci., December 1, 2004; 45(12): 4583 - 4591.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
J. S. Penn and V. S. Rajaratnam
Inhibition of Retinal Neovascularization by Intravitreal Injection of Human rPAI-1 in a Rat Model of Retinopathy of Prematurity
Invest. Ophthalmol. Vis. Sci., December 1, 2003; 44(12): 5423 - 5429.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the Association for Research in Vision and Ophthalmology